Advertisement

Topics

Puma Biotechnology, Inc. Company Profile

12:28 EDT 26th May 2016 | BioPortfolio

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.


News Articles [343 Associated News Articles listed on BioPortfolio]

Puma Biotechnology to Present at UBS Global Healthcare Conference

Tuesday, May 17th 2016 at 12:35pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Exec...

BRIEF-Puma Biotechnology reports Q1 loss per share $2.19

* Puma biotechnology reports first quarter 2016 financial results

Puma Biotechnology to Present at Bank of America Merrill Lynch Health Care Conference

Wednesday, May 4th 2016 at 12:35pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Exe...

Puma Continues Long Post-ASCO Plunge On Latest Data

Puma Biotechnology Inc.'s data for the tyrosine kinase inhibitor neratinib (PB272) in the treatment of breast cancer now seem to disappoint investors every time the Los Angeles-based company reports r...

Puma plunges as filing date for neratinib delayed

Puma Biotechnology says that, following recent meetings with the Food and Drug Administration, the company…

Puma Biotechnology Reports First Quarter 2016 Financial Results

Tuesday, May 10th 2016 at 8:17pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced financial results for the first quarter ende...

Puma Biotechnology's ExteNET Phase III Study Published

Puma Biotechnology, Inc., a biopharmaceutical company, announced that results from the ExteNET Phase III clinical trial of neratinib in patients with early stage HER2 positive breast cancer were publi...

Puma Biotechnology’s NEfERT-T Phase II Study Published Online in JAMA Oncology

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company, announced that results from the NEfERT-T Phase II clinical trial of neratinib in ERBB2-posit...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

PubMed Articles [414 Associated PubMed Articles listed on BioPortfolio]

Role of PUMA in methamphetamine-induced neuronal apoptosis.

Exposure to methamphetamine (METH), a widely used illicit drug, has been shown to cause neuron apoptosis. p53 upregulated modulator of apoptosis (PUMA) is a key mediator in neuronal apoptosis. This st...

Uncoupling of PUMA Expression and Apoptosis Contributes to Functional Heterogeneity in Renal Cell Carcinoma - Prognostic and Translational Implications.

Renal cell carcinoma (RCC) is characterized by a profound disruption of proapoptotic signaling networks leading to chemo- and radioresistance. A key mediator of DNA damage-induced apoptosis is the BH3...

Quantification of Unmethylated Alu (QUAlu): a tool to assess global hypomethylation in routine clinical samples.

Hypomethylation of DNA is a hallmark of cancer and its analysis as tumor biomarker has been proposed, but its determination in clinical settings is hampered by lack of standardized methodologies. Here...

Students' knowledge of, and attitudes towards biotechnology revisited, 1995-2014: Changes in agriculture biotechnology but not in medical biotechnology.

Modern biotechnology is one of the most important scientific and technological revolutions in the 21st century, with an increasing and measurable impact on society. Development of biotechnology curric...

Survival and Mortality of Pumas (Puma concolor) in a Fragmented, Urbanizing Landscape.

Wide-ranging large carnivores pose myriad challenges for conservation, especially in highly fragmented landscapes. Over a 13-year period, we combined monitoring of radio collared pumas (Puma concolor)...

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors

In the laboratory, Kevetrin activates p53, a tumor suppressor protein that has an important role in protecting the body. p53 functions by activating proteins that repair DNA and kill cells...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old

This study will be a Phase I, randomized, double blind, safety and immunogenicity trial of the Vero cell based 116E neonatal rotavirus vaccine candidate strain in healthy non-malnourished ...

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

Influenza is an acute respiratory disease caused by influenza viruses. There are three types of the virus including A, B and C. Both type A and type B viruses can cause acute febrile respi...

Companies [875 Associated Companies listed on BioPortfolio]

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company ...

PUMA

Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understand...

Missouri Biotechnology Association

The Missouri Biotechnology Association is focused on maintaining the growth of the biotechnology industry generated by the research and development communities of Missouri. While we have made great st...

Swiss Biotech Association (SBA)

The Swiss Biotech Association (SBA) is the national association representing biotechnology companies, academic institutions, regional biotechnology centres and related organisations throughout Switzer...

More Information about "Puma Biotechnology, Inc." on BioPortfolio

We have published hundreds of Puma Biotechnology, Inc. news stories on BioPortfolio along with dozens of Puma Biotechnology, Inc. Clinical Trials and PubMed Articles about Puma Biotechnology, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Puma Biotechnology, Inc. Companies in our database. You can also find out about relevant Puma Biotechnology, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record